Compared to Estimates, Zoetis (ZTS) Q4 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2225588/compared-to-estimates-zoetis-zts-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2225588
Feb 13, 2024 - The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Zoetis (ZTS) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/02/13/zoetis-zts-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Feb 13, 2024 - ZTS earnings call for the period ending December 31, 2023.
0
Zoetis' (ZTS) Q4 Earnings Miss Expectations, Sales Beat
https://www.zacks.com/stock/news/2225640/zoetis-zts-q4-earnings-miss-expectations-sales-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2225640
Feb 13, 2024 - Zoetis (ZTS) reports mixed fourth-quarter results, wherein earnings miss estimates while revenues beat the same.
0
GRFS or ZTS: Which Is the Better Value Stock Right Now?
https://www.zacks.com/stock/news/2226324/grfs-or-zts-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2226324
Feb 14, 2024 - GRFS vs. ZTS: Which Stock Is the Better Value Option?
0
Company News for Feb 14, 2024
https://www.zacks.com/stock/news/2226118/company-news-for-feb-14-2024?cid=CS-ZC-FT-corporate_summary-2226118
Feb 14, 2024 - Companies in The News Are: ZTS,MAR,ECL,HAS
0
1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now
https://www.fool.com/investing/2024/02/26/1-magnificent-sp-500-dividend-stock-down-23-to-buy/?source=iedfolrf0000001
Feb 26, 2024 - Buoyed by megatrends in animal healthcare, this stock makes for an excellent holding in almost any portfolio.
0
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
https://www.zacks.com/stock/news/2259683/zoetis-zts-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2259683
Apr 22, 2024 - In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day.
0
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
https://www.zacks.com/stock/news/2264204/biocryst-pharmaceuticals-bcrx-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2264204
Apr 29, 2024 - BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Pages: 1
Page 1